- Geoff Watts
- 1London
A study of 295 patients with Alzheimer’s disease has shown that the drug donepezil and memantine, already used in the mild to moderate stage of the illness, are also beneficial in its moderate to severe stage.
“Overall this is an important study,” said Clive Ballard, one of the study’s coauthors and director of research at the Alzheimer’s Society. “It’s informed an issue where previously there wasn’t any evidence, and it’s allowed us to think about the drug treatment of Alzheimer’s disease in a smarter way.”
The new findings, reported in the New England Journal of Medicine (2012;136:893-903), are the outcome of the DOMINO trial funded by the Medical Research Council and the Alzheimer’s Society. This …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.